(Q38101007)

28 August 2017

Sulfonylureas and risk of falls and fractures: a systematic review (English)

1 reference

28 August 2017

1 reference

1 reference

1

Kate L Lapane

1 reference

28 August 2017

Shibing Yang

2

1 reference

28 August 2017

Monique J Brown

3

1 reference

28 August 2017

Rachel Jawahar

4

1 reference

28 August 2017

Caleb Pagliasotti

5

1 reference

28 August 2017

Swapnil Rajpathak

6

1 reference

28 August 2017

1 July 2013

1 reference

28 August 2017

1 reference

28 August 2017

30

1 reference

28 August 2017

7

1 reference

28 August 2017

527-547

1 reference

https://scigraph.springernature.com/pub.10.1007/s40266-013-0081-0

28 August 2017

0 references

cites work

Drug-induced hypoglycaemia: an update

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Use of thiazolidinediones and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Fracture risk in type 2 diabetes: update of a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

A critical review of bone mass and the risk of fractures in osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Diabetes and risk of fracture: The Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Forearm endothelial function and bone mineral loss in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

How to write a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Thiazolidinediones and fractures: evidence from translating research into action for diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Thiazolidinediones and fractures in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

A cohort study of thiazolidinediones and fractures in older adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

21 January 2018

Are sulfonylureas passé?

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Insulin use in elderly adults: risk of hypoglycemia and strategies for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Physiological changes due to age. Pharmacodynamic changes of drug action and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Deadly drug interactions in emergency medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-013-0081-0

Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications

21 January 2018

1 reference

12 December 2020

Polypharmacy: a new paradigm for quality drug therapy in the elderly?

1 reference

12 December 2020

Risk factors for serious injury during falls by older persons in the community

1 reference

12 December 2020

Impact of peripheral neuropathy on bone density in patients with type 1 diabetes

1 reference

12 December 2020

10.1007/S40266-013-0081-0

Identifiers

DOI

1 reference

28 August 2017

1 reference